While citizens focus on the latest issue the government directs our attention to, many of us have lost sight of the big picture and grown accustomed to severe limitations on our rights like the proverbial frogs in hot water. As a number of countries now seek to focus the discussion on further coercive measures and even mandatory vaccination, PANDA is increasingly aware of the elephants in the room, the topics no one is talking about.
I reiterate our call: “slow down and get the science right—there is no legitimate reason to hurry to grant a license to a coronavirus vaccine.”
FDA should be demanding that the companies complete the two year follow-up, as originally planned (even without a placebo group, much can still be learned about safety). They should demand adequate, controlled studies using patient outcomes in the now substantial population of people who have recovered from covid. And regulators should bolster public trust by helping ensure that everyone can access the underlying data.